<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00197795</url>
  </required_header>
  <id_info>
    <org_study_id>MNB1</org_study_id>
    <nct_id>NCT00197795</nct_id>
  </id_info>
  <brief_title>Immunogenicity and Reactogenicity of a Meningococcal B Outer Membrane Vesicle Vaccine Given in a 0,6,12 Month Schedule to Health UK Adults</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Public Health England</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Public Health England</source>
  <brief_summary>
    <textblock>
      To measure the serum bactericidal antibody levels and cell mediated immune responses before
      and six weeks after each dose of meningococcal outer membrane vesicle vaccine given at 0,6
      and 12 weeks to healthy UK adults.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2005</start_date>
  <completion_date type="Actual">December 2006</completion_date>
  <primary_completion_date type="Actual">December 2006</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <enrollment>30</enrollment>
  <condition>Neisseria Meningitidis</condition>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Meningococcal outer membrane vesicle vaccine &quot;MenBVac&quot;</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Informed written consent given for three immunizations with MenBVac and five blood
             tests

          -  Between the ages of 18 and 55 years inclusive at recruitment

        Exclusion Criteria:

          -  Previous history of bacteriologically confirmed meningococcal disease

          -  History of clinically significant allergic sensitivity to any vaccine received in the
             past

          -  Immunodeficiency

          -  Any other acute or chronic systemic illness or dependence or abuse of drugs or alcohol

          -  Language difficulties sufficient to preclude adequate comprehension of the study
             information

          -  Possibility of pregnancy

          -  Receipt of any other vaccine in the previous 4 weeks

          -  Receipt of any group B vaccine in the past

          -  Current participation in any other clinical trial

          -  Generalized acute systemic illness and/or temp &gt;38C on day of vaccination deferral
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Elizabeth Miller, MBBS FRCPath</last_name>
    <role>Principal Investigator</role>
    <affiliation>Public Health England</affiliation>
  </overall_official>
  <results_reference>
    <citation>Findlow J, Taylor S, Aase A, Horton R, Heyderman R, Southern J, Andrews N, Barchha R, Harrison E, Lowe A, Boxer E, Heaton C, Balmer P, Kaczmarski E, Oster P, Gorringe A, Borrow R, Miller E. Comparison and correlation of neisseria meningitidis serogroup B immunologic assay results and human antibody responses following three doses of the Norwegian meningococcal outer membrane vesicle vaccine MenBvac. Infect Immun. 2006 Aug;74(8):4557-65. Erratum in: Infect Immun. 2007 Aug;75(8):4187.</citation>
    <PMID>16861642</PMID>
  </results_reference>
  <verification_date>March 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 12, 2005</study_first_submitted>
  <study_first_submitted_qc>September 12, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 20, 2005</study_first_posted>
  <last_update_submitted>March 27, 2012</last_update_submitted>
  <last_update_submitted_qc>March 27, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 28, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Public Health England</investigator_affiliation>
    <investigator_full_name>Dr. Elizabeth Miller</investigator_full_name>
    <investigator_title>Consultant epidemiologist</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vaccines</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

